Free Trial

SiriusPoint Ltd. (NYSE:SPNT) Shares Acquired by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

SiriusPoint logo with Finance background

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its holdings in SiriusPoint Ltd. (NYSE:SPNT - Free Report) by 17.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 198,852 shares of the company's stock after purchasing an additional 28,918 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned approximately 0.12% of SiriusPoint worth $3,259,000 at the end of the most recent quarter.

Other hedge funds have also modified their holdings of the company. Capital Research Global Investors boosted its position in SiriusPoint by 17.8% during the fourth quarter. Capital Research Global Investors now owns 6,300,000 shares of the company's stock worth $103,257,000 after acquiring an additional 950,000 shares during the last quarter. Donald Smith & CO. Inc. increased its stake in SiriusPoint by 12.9% in the fourth quarter. Donald Smith & CO. Inc. now owns 7,887,887 shares of the company's stock valued at $129,282,000 after purchasing an additional 900,209 shares during the last quarter. Wellington Management Group LLP lifted its position in SiriusPoint by 8.5% during the fourth quarter. Wellington Management Group LLP now owns 10,694,214 shares of the company's stock worth $175,278,000 after buying an additional 838,262 shares during the period. Gilder Gagnon Howe & Co. LLC lifted its position in SiriusPoint by 12.8% during the fourth quarter. Gilder Gagnon Howe & Co. LLC now owns 2,643,704 shares of the company's stock worth $43,330,000 after buying an additional 299,114 shares during the period. Finally, Price T Rowe Associates Inc. MD boosted its stake in SiriusPoint by 481.8% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 317,560 shares of the company's stock worth $5,206,000 after buying an additional 262,981 shares during the last quarter. 52.79% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several research analysts have recently weighed in on SPNT shares. DOWLING & PARTN upgraded shares of SiriusPoint from a "hold" rating to a "strong-buy" rating in a report on Thursday, March 6th. Wall Street Zen raised shares of SiriusPoint from a "buy" rating to a "strong-buy" rating in a research note on Saturday, May 24th. Finally, Jefferies Financial Group initiated coverage on shares of SiriusPoint in a research note on Tuesday, April 15th. They set a "hold" rating and a $17.00 price objective for the company.

Check Out Our Latest Analysis on SPNT

SiriusPoint Trading Down 0.8%

Shares of SiriusPoint stock traded down $0.16 during trading hours on Monday, reaching $19.23. The stock had a trading volume of 548,333 shares, compared to its average volume of 620,460. The firm has a market capitalization of $2.24 billion, a price-to-earnings ratio of 20.03 and a beta of 0.86. SiriusPoint Ltd. has a 1 year low of $11.92 and a 1 year high of $19.87. The company has a current ratio of 0.57, a quick ratio of 0.56 and a debt-to-equity ratio of 0.37. The firm has a 50 day simple moving average of $17.91 and a two-hundred day simple moving average of $16.03.

SiriusPoint (NYSE:SPNT - Get Free Report) last announced its quarterly earnings results on Monday, May 5th. The company reported $0.49 earnings per share for the quarter, beating analysts' consensus estimates of $0.26 by $0.23. SiriusPoint had a net margin of 7.68% and a return on equity of 8.73%. The firm had revenue of $727.30 million for the quarter, compared to analysts' expectations of $688.00 million.

Insider Activity at SiriusPoint

In related news, Director La Gueronniere Rafe De sold 30,000 shares of the business's stock in a transaction that occurred on Thursday, May 8th. The stock was sold at an average price of $19.55, for a total transaction of $586,500.00. Following the transaction, the director now directly owns 127,578 shares of the company's stock, valued at approximately $2,494,149.90. The trade was a 19.04% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Company insiders own 11.70% of the company's stock.

About SiriusPoint

(Free Report)

SiriusPoint Ltd. provides multi-line insurance and reinsurance products and services worldwide. The company operates through two segments, Reinsurance, and Insurance & Services. The Reinsurance segment provides aviation and space, accident and health, casualty, credit, marine and energy, property to insurance and reinsurance companies, government entities, and other risk bearing vehicles.

Further Reading

Institutional Ownership by Quarter for SiriusPoint (NYSE:SPNT)

Should You Invest $1,000 in SiriusPoint Right Now?

Before you consider SiriusPoint, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SiriusPoint wasn't on the list.

While SiriusPoint currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Analysts Are Watching These 4 Penny Stocks—You Should Too
Congress Is Pouring Millions Into These 6 Surprising Stocks
3 Dirt-Cheap Stocks in a Market That’s Getting Expensive

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines